Literature DB >> 30114408

Influence of collection tubes during quantitative targeted metabolomics studies in human blood samples.

Giuseppe Paglia1, Fabiola M Del Greco2, Baldur B Sigurdsson3, Johannes Rainer2, Chiara Volani4, Andrew A Hicks2, Peter P Pramstaller2, Sigurdur V Smarason2.   

Abstract

BACKGROUND: Plasma and serum are the most widely used matrices in clinical studies. However, some variability in absolute concentrations of metabolites are likely to be observed in these collection tubes matrices.
METHODS: We analyzed 189 metabolites using the same protocol for quantitative targeted metabolomics (LC-MS/MS AbsoluteIDQ p180 Kit Biocrates) in three types of samples, serum, plasma EDTA and citrate, of 80 subjects from the Cooperative Health Research In South Tyrol cohort (40 healthy elderly and 40 healthy young).
RESULTS: The concentration levels were higher in serum than citrate and EDTA, in particular for amino acids and biogenic amines. The average Pearson's correlation coefficients were however always higher than 0.7 for these two classes of metabolites. We could also demonstrate that blank EDTA vacutainer tubes contain a significant amount of sarcosine. Finally, we compared the metabolome of young people against elderly subjects and found that the highest number of metabolites significantly changing with age was detected in serum.
CONCLUSION: Serum samples provide higher sensitivity for biomarker discovery studies. Due to the presence of spurious amount of sarcosine in vacutainer EDTA tubes, plasma EDTA is not suitable for studies requiring accurate quantification of sarcosine.
Copyright © 2018 The Authors. Published by Elsevier B.V. All rights reserved.

Entities:  

Keywords:  AbsoluteIDQ p180 kit biocrates; Plasma EDTA; Plasma citrate; Sarcosine; Serum; Targeted metabolomics

Mesh:

Substances:

Year:  2018        PMID: 30114408     DOI: 10.1016/j.cca.2018.08.014

Source DB:  PubMed          Journal:  Clin Chim Acta        ISSN: 0009-8981            Impact factor:   3.786


  12 in total

Review 1.  Nutritional Metabolomics in Cancer Epidemiology: Current Trends, Challenges, and Future Directions.

Authors:  Emma E McGee; Rama Kiblawi; Mary C Playdon; A Heather Eliassen
Journal:  Curr Nutr Rep       Date:  2019-09

2.  Mass Spectrometry-Based Plasma Proteomics: Considerations from Sample Collection to Achieving Translational Data.

Authors:  Vera Ignjatovic; Philipp E Geyer; Krishnan K Palaniappan; Jessica E Chaaban; Gilbert S Omenn; Mark S Baker; Eric W Deutsch; Jochen M Schwenk
Journal:  J Proteome Res       Date:  2019-10-11       Impact factor: 4.466

Review 3.  Metabolomics in asthma: A platform for discovery.

Authors:  Shengjie Xu; Reynold A Panettieri; Joseph Jude
Journal:  Mol Aspects Med       Date:  2021-07-17

4.  Impact of Blood Collection Tubes and Sample Handling Time on Serum and Plasma Metabolome and Lipidome.

Authors:  Charmion Cruickshank-Quinn; Laura K Zheng; Kevin Quinn; Russell Bowler; Richard Reisdorph; Nichole Reisdorph
Journal:  Metabolites       Date:  2018-12-04

5.  Prospective epidemiological, molecular, and genetic characterization of a novel coronavirus disease in the Val Venosta/Vinschgau: the CHRIS COVID-19 study protocol.

Authors:  Cristian Pattaro; Giulia Barbieri; Luisa Foco; Christian X Weichenberger; Roberta Biasiotto; Alessandro De Grandi; Christian Fuchsberger; Clemens Egger; Vera S C Amon; Andrew A Hicks; Michael Mian; Angelika Mahlknecht; Stefano Lombardo; Horand Meier; Helmuth Weiss; Robert Rainer; Christian Dejaco; Günter Weiss; Enrico Lavezzo; Andrea Crisanti; Massimo Pizzato; Francisco S Domingues; Deborah Mascalzoni; Martin Gögele; Roberto Melotti; Peter P Pramstaller
Journal:  Pathog Glob Health       Date:  2021-10-12       Impact factor: 2.894

6.  Diet Alters Serum Metabolomic Profiling in the Mouse Model of Chronic Chagas Cardiomyopathy.

Authors:  Kezia Lizardo; Janeesh Plakkal Ayyappan; Usha Ganapathi; Walderez O Dutra; Yunping Qiu; Louis M Weiss; Jyothi F Nagajyothi
Journal:  Dis Markers       Date:  2019-12-20       Impact factor: 3.434

7.  Metabolic Signature of Arrhythmogenic Cardiomyopathy.

Authors:  Chiara Volani; Johannes Rainer; Vinicius Veri Hernandes; Viviana Meraviglia; Peter Paul Pramstaller; Sigurður Vidir Smárason; Giulio Pompilio; Michela Casella; Elena Sommariva; Giuseppe Paglia; Alessandra Rossini
Journal:  Metabolites       Date:  2021-03-25

8.  A Comparison of Serum and Plasma Blood Collection Tubes for the Integration of Epidemiological and Metabolomics Data.

Authors:  Jennie Sotelo-Orozco; Shin-Yu Chen; Irva Hertz-Picciotto; Carolyn M Slupsky
Journal:  Front Mol Biosci       Date:  2021-07-08

9.  Amino Acid and Phospholipid Metabolism as an Indicator of Inflammation and Subtle Cardiomyopathy in Patients with Marfan Syndrome.

Authors:  Lisa Bartenbach; Thomas Karall; Jakob Koch; Markus Andreas Keller; Herbert Oberacher; Sabine Scholl-Bürgi; Daniela Karall; Gregor Oemer; Daniela Baumgartner; Katharina Meinel; Safwat Aly; Irena Odri-Komazec; Ralf Geiger; Miriam Michel
Journal:  Metabolites       Date:  2021-11-27

Review 10.  From bedside to bench-practical considerations to avoid pre-analytical pitfalls and assess sample quality for high-resolution metabolomics and lipidomics analyses of body fluids.

Authors:  Rainer Lehmann
Journal:  Anal Bioanal Chem       Date:  2021-06-22       Impact factor: 4.142

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.